Cephalexin Capsule
NDC Package 0093-3147-01
Package Information
Cephalexin capsules is a medication used to treat a wide variety of bacterial infections. This formulation utilizes a capsule delivery system. Marketed by Teva Pharmaceuticals Usa, Inc., this product is identified by NDC 0093-3147 and is authorized under FDA application ANDA062702.
Identification & Billing
- RxCUI: 309110 - cephalexin 125 MG in 5 mL Oral Suspension
- RxCUI: 309110 - cephalexin 25 MG/ML Oral Suspension
- RxCUI: 309110 - cefalexin 25 MG/ML Oral Suspension
- RxCUI: 309110 - cephalexin 125 MG per 5 ML Oral Suspension
- RxCUI: 309112 - cephalexin 250 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0093 - Teva Pharmaceuticals Usa, Inc.
- 0093-3147 - Cephalexin
- 0093-3147-01 - 100 CAPSULE in 1 BOTTLE
- 0093-3147 - Cephalexin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0093-3147). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0093-3147-01 identifies a specific commercial package of 100 capsule in 1 bottle of Cephalexin, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. This capsule is formulated for oral use and contains cephalexin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Teva Pharmaceuticals Usa, Inc. on September 30, 1990. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.
How is this Teva Pharmaceuticals Usa, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00093314701. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.